share_log

Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024

Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024

sensus healthcare将于2024年11月14日星期四举行第三季度财务业绩和业务更新电话会议。
GlobeNewswire ·  10/31 08:00

BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 14, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones.

佛罗里达州博卡拉顿,2024年10月31日(GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (纳斯达克: SRTS),一家专门从事肿瘤和非肿瘤病况的高效非侵入式治疗的医疗器械公司,宣布管理层将于2024年11月14日星期四下午4:30在美国东部时间召开电话会议,讨论2024年第三季度的财务业绩。此外,管理层还将提供业务更新和就最近和即将到来的里程碑进行讨论。

Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial-in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register can access the conference call by dialing 844-481-2811 (U.S. and Canada Toll Free) or 412-317-0676 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.

鼓励参与者使用此链接提前注册电话会议。注册后,参与者将收到一个独特的拨入号码,允许他们绕过现场运营商。参与者可以随时提前注册,包括在开始通话时间之前和之后。那些没有网络访问权限或无法提前注册的人员可以通过拨打844-481-2811(美国和加拿大免费电话)或412-317-0676(国际电话)接入电话会议。请指示运营商将您连接到Sensus Healthcare电话会议。

The call will be webcast live and can be accessed at this link, which also can be found in the Investor Relations section of the Company's website at .

电话会议将通过此链接现场网络直播,也可以在公司网站的投资者关系部分找到。

Following the conclusion of the conference call, a telephone replay will be available until December 14, 2024 and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free) or 412-317-0088 (International). At the system prompt, enter the replay code 3932512 followed by the # sign. An archived webcast of the call will also be available in the Investor Relations section of the Company's website for a period of time.

电话会议结束后,电话重播将持续至2024年12月14日,可通过拨打877-344-7529(美国免费电话),855-669-9658(加拿大免费电话)或412-317-0088(国际电话)进行访问。在系统提示音后,输入重播代码3932512,然后按#号键。电话会议的存档网络视频也将在公司网站的投资者关系部分提供一段时间。

About Sensus Healthcare, Inc.

关于sensus healthcare,Inc。

Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit .

sensus healthcare,Inc。是全球皮肤癌和瘢痕非侵入性治疗开发和提供的先驱。利用其尖端的表浅放疗(SRt和IG-SRT)技术,该公司为医疗保健提供者提供高效、以患者为中心的治疗平台。致力于推动放射肿瘤学创新的sensus healthcare提供安全、精准、适用于各种临床设置的解决方案。欲了解更多信息,请访问。

Contact:
Alliance Advisors IR
Kim Sutton Golodetz
212-838-3777
kgolodetz@allianceadvisors.com

Brian Siegel,IRC,MBA-高级管理董事,Hayden IR,电话:(346)396-8696,ir@zedge.net
Alliance Advisors IR
Kim Sutton Golodetz
212-838-3777
kgolodetz@allianceadvisors.com

# # #

# # #


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发